- Home
- OBIO vs ORGN Comparison
OBIO vs ORGN Comparison
Compare OBIO & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- ORGN
- Stock Information
- Founded
- OBIO 2017
- ORGN 2008
- Country
- OBIO United States
- ORGN United States
- Employees
- OBIO N/A
- ORGN N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- ORGN Major Chemicals
- Sector
- OBIO Health Care
- ORGN Industrials
- Exchange
- OBIO Nasdaq
- ORGN Nasdaq
- Market Cap
- OBIO 200.1M
- ORGN 199.7M
- IPO Year
- OBIO N/A
- ORGN N/A
- Fundamental
- Price
- OBIO $5.84
- ORGN $1.09
- Analyst Decision
- OBIO Strong Buy
- ORGN Strong Buy
- Analyst Count
- OBIO 4
- ORGN 1
- Target Price
- OBIO $15.75
- ORGN $3.00
- AVG Volume (30 Days)
- OBIO 57.1K
- ORGN 1.1M
- Earning Date
- OBIO 11-12-2024
- ORGN 11-14-2024
- Dividend Yield
- OBIO N/A
- ORGN N/A
- EPS Growth
- OBIO N/A
- ORGN N/A
- EPS
- OBIO N/A
- ORGN N/A
- Revenue
- OBIO $2,647,000.00
- ORGN $35,123,000.00
- Revenue This Year
- OBIO $7.68
- ORGN $10.62
- Revenue Next Year
- OBIO $110.40
- ORGN $175.99
- P/E Ratio
- OBIO N/A
- ORGN N/A
- Revenue Growth
- OBIO N/A
- ORGN 123.12
- 52 Week Low
- OBIO $4.22
- ORGN $0.44
- 52 Week High
- OBIO $11.69
- ORGN $1.90
- Technical
- Relative Strength Index (RSI)
- OBIO 51.19
- ORGN 24.46
- Support Level
- OBIO $5.56
- ORGN $1.19
- Resistance Level
- OBIO $6.50
- ORGN $1.35
- Average True Range (ATR)
- OBIO 0.53
- ORGN 0.07
- MACD
- OBIO 0.00
- ORGN -0.02
- Stochastic Oscillator
- OBIO 56.58
- ORGN 10.26
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others.